Back
First Trust Securitized Plus ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Sell
37
DEED
First Trust Securitized Plus ETF
Last Price:
$21.56
Seasonality Move:
-3.79%
Buy
54
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$60.16
Seasonality Move:
5.52%
Sell
37
First Trust Securitized Plus ETF (DEED)
is a Sell
Is First Trust Securitized Plus ETF a Buy, Sell or Hold?
-
The current First Trust Securitized Plus ETF [DEED] share price is $21.56. The Score for DEED is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DEED is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.14. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DEED Stock Price Chart
What is First Trust Securitized Plus ETF's stock price today?
-
The First Trust Securitized Plus ETF share price today is $21.56The current trend is relatively stagnant and DEED is experiencing slight buying pressure.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $61.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
DEED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 50.09 | Buy |
| Chaikin Money Flow: | 17891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.52 - 21.64) | Sell |
| Bollinger Bands (100): | (21.27 - 21.61) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 69.03 | Buy |
| Chaikin Money Flow: | 2115867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52 - 57.1) | Buy |
| Bollinger Bands (100): | (52.63 - 57.55) | Buy |
DEED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.54 | Buy |
| 20-day SMA: | 21.58 | Sell |
| 50-day SMA: | 21.56 | Sell |
| 200-day SMA: | 21.22 | Buy |
| 8-day EMA: | 21.56 | Buy |
| 20-day EMA: | 21.56 | Buy |
| 50-day EMA: | 21.18 | Buy |
| 200-day EMA: | 13.73 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.32 | Buy |
| 20-day SMA: | 54.72 | Buy |
| 50-day SMA: | 53.92 | Buy |
| 200-day SMA: | 57.83 | Buy |
| 8-day EMA: | 56.77 | Buy |
| 20-day EMA: | 55.12 | Buy |
| 50-day EMA: | 54.57 | Buy |
| 200-day EMA: | 58.32 | Buy |
First Trust Securitized Plus ETF Earnings Growth & DEED Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.74 per share.
First Trust Securitized Plus ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||